U.S. markets close in 1 hour 9 minutes

Soaring Eagle Acquisition Corp. (SRNGU)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
11.97+1.34 (+12.61%)
As of 4:00PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close10.63
Open10.64
Bid0.00 x 1200
Ask0.00 x 1400
Day's Range11.97 - 11.97
52 Week Range9.38 - 12.07
Volume589,824
Avg. Volume500,600
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds

      Ginkgo Bioworks, Inc. ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), a special purpose acquisition company, today announced the closing of their previously announced business combination. The combined company is named Ginkgo Bioworks Holdings, Inc., and the combined company's shares of Class A common stock and public warrants will begin trading today on the New York Stock Exchange under the ticker symbols "DNA" and "DNA.WS" respectively. The business combination

    • Business Wire

      Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds

      NEW YORK, September 14, 2021--Soaring Eagle Acquisition Corp. (the "Company" or "Soaring Eagle") (Nasdaq: SRNGU, SRNG, SRNGW) announced today that its business combination (the "Business Combination") with Ginkgo Bioworks, Inc. ("Ginkgo") was overwhelmingly approved in a shareholder vote held this morning, with 75% of shareholders participating in the vote and 97% voting in favor of the combination. Upon the closing of the Business Combination (the "Closing"), Ginkgo Bioworks expects to receive

    • PR Newswire

      Concentric by Ginkgo Stands Ready to Continue Fighting Pandemic, Providing Biosecurity and COVID Testing Nationwide to Schools, Workplaces, and Other Congregate Settings

      Ginkgo Bioworks ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced its readiness to continue scaling support for COVID testing in congregate settings in response to new emergency standards and recommendations issued by the Biden-Harris Administration. Ginkgo, which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), serves customers across industries seeking to develop new and better products using biolog